← Leaderboards
Yvonne Yu-Hsuan Chen
University Of California Los Angeles
$4,496,748
Attributed
$4,496,748
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $955.6K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,496,748 · 3
By mechanism
R01$1,820,675 · 1
DP5$1,658,742 · 1
P50$1,017,331 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Antoni Ribas$28,929,216
- Robert M Prins$8,963,397
- Robert E Reiter$11,316,970
- Richard C Koya$2,268,595
- James S. Economou$9,911,213
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoToxic EffectXenograft ModelImmunotherapyEngineeringTransforming Growth Factor BetaT-LymphocyteTumorResponseNeoplastic CellSignal TransductionSafetyCellsImmuneAntigensCytokineClinical EfficacyImmune ResponseImmune SystemSpecificityImmunosuppressive AgentsOperative Surgical ProceduresCytotoxicityAdoptive Transfer
Grant awards (12)
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.$610,097
R01 · FY2025 · NS · contact PI
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy$328,895
P50 · FY2025 · CA · contact PI
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy$8,612
P50 · FY2025 · CA · contact PI
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.$597,570
R01 · FY2024 · NS · contact PI
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy$337,209
P50 · FY2024 · CA · contact PI
Programming multi-pronged immune response to glioblastoma with IL-13Ra2/TGF-b CAR-T cell therapy.$613,008
R01 · FY2023 · NS · contact PI
Targeting Glioblastoma Cells and Tumor Microenvironment with CAR-T Cell Therapy$342,615
P50 · FY2023 · CA · contact PI
Engineering of computational receptors and gene circuits for T-cell immunotherapy$341,185
DP5 · FY2016 · OD · contact PI
Engineering of computational receptors and gene circuits for T-cell immunotherapy$341,675
DP5 · FY2015 · OD · contact PI
Engineering of computational receptors and gene circuits for T-cell immunotherapy$342,150
DP5 · FY2014 · OD · contact PI
Engineering of computational receptors and gene circuits for T-cell immunotherapy$332,333
DP5 · FY2013 · OD · contact PI
Engineering of computational receptors and gene circuits for T-cell immunotherapy$301,399
DP5 · FY2012 · OD · contact PI